Suppliers / JHP Pharmaceuticals

JHP Pharmaceuticals

United States Updated 9 July 2026

JHP Pharmaceuticals is a finished-dose manufacturer based in United States. It appears in 21 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with Health Canada and ARCSA (EC).

0
active US DMFs
0
valid CEPs
0
registered plants
21
filings across 2 regulators

Filings and GMP by regulator

Regulator Filings GMP certificates
Health Canada 19 None
ARCSA (EC) 2 None

Limited public record

Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.

Questions about JHP Pharmaceuticals

Does JHP Pharmaceuticals hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for JHP Pharmaceuticals. It does have 21 filings with 2 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Where does JHP Pharmaceuticals file?
Filings are on record with Health Canada and ARCSA (EC), 21 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. JHP Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability